Global and United States Generic Oncology Drugs Market Report & Forecast 2024-2031

Report ID: 1844545 | Published Date: Oct 2024 | No. of Page: 102 | Base Year: 2023 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Generic Oncology Drugs Revenue in Generic Oncology Drugs Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Generic Oncology Drugs Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Generic Oncology Drugs Market Size for the Year 2017-2028
        1.2.2 Global Generic Oncology Drugs Market Size for the Year 2017-2028
    1.3 Generic Oncology Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Generic Oncology Drugs in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Generic Oncology Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Generic Oncology Drugs Market Dynamics
        1.4.1 Generic Oncology Drugs Industry Trends
        1.4.2 Generic Oncology Drugs Market Drivers
        1.4.3 Generic Oncology Drugs Market Challenges
        1.4.4 Generic Oncology Drugs Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Generic Oncology Drugs by Type
    2.1 Generic Oncology Drugs Market Segment by Type
        2.1.1 Large Molecule Drugs
        2.1.2 Small Molecule Drugs
    2.2 Global Generic Oncology Drugs Market Size by Type (2017, 2022 & 2028)
    2.3 Global Generic Oncology Drugs Market Size by Type (2017-2028)
    2.4 United States Generic Oncology Drugs Market Size by Type (2017, 2022 & 2028)
    2.5 United States Generic Oncology Drugs Market Size by Type (2017-2028)
3 Generic Oncology Drugs by Application
    3.1 Generic Oncology Drugs Market Segment by Application
        3.1.1 Hospital Pharmacies
        3.1.2 Retail Pharmacies
        3.1.3 Online Pharmacies
    3.2 Global Generic Oncology Drugs Market Size by Application (2017, 2022 & 2028)
    3.3 Global Generic Oncology Drugs Market Size by Application (2017-2028)
    3.4 United States Generic Oncology Drugs Market Size by Application (2017, 2022 & 2028)
    3.5 United States Generic Oncology Drugs Market Size by Application (2017-2028)
4 Global Generic Oncology Drugs Competitor Landscape by Company
    4.1 Global Generic Oncology Drugs Market Size by Company
        4.1.1 Top Global Generic Oncology Drugs Companies Ranked by Revenue (2021)
        4.1.2 Global Generic Oncology Drugs Revenue by Player (2017-2022)
    4.2 Global Generic Oncology Drugs Concentration Ratio (CR)
        4.2.1 Generic Oncology Drugs Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Generic Oncology Drugs in 2021
        4.2.3 Global Generic Oncology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Generic Oncology Drugs Headquarters, Revenue in Generic Oncology Drugs Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Generic Oncology Drugs Headquarters and Area Served
        4.3.2 Global Generic Oncology Drugs Companies Revenue in Generic Oncology Drugs Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Generic Oncology Drugs Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Generic Oncology Drugs Market Size by Company
        4.5.1 Top Generic Oncology Drugs Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Generic Oncology Drugs Revenue by Players (2020, 2021 & 2022)
5 Global Generic Oncology Drugs Market Size by Region
    5.1 Global Generic Oncology Drugs Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Generic Oncology Drugs Market Size by Region (2017-2028)
        5.2.1 Global Generic Oncology Drugs Market Size by Region: 2017-2022
        5.2.2 Global Generic Oncology Drugs Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Generic Oncology Drugs Market Size YoY Growth 2017-2028
        6.1.2 North America Generic Oncology Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Generic Oncology Drugs Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Generic Oncology Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Generic Oncology Drugs Market Size YoY Growth 2017-2028
        6.3.2 Europe Generic Oncology Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Generic Oncology Drugs Market Size YoY Growth 2017-2028
        6.4.2 Latin America Generic Oncology Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Generic Oncology Drugs Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Generic Oncology Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Pfizer
        7.1.1 Pfizer Company Details
        7.1.2 Pfizer Business Overview
        7.1.3 Pfizer Generic Oncology Drugs Introduction
        7.1.4 Pfizer Revenue in Generic Oncology Drugs Business (2017-2022)
        7.1.5 Pfizer Recent Development
    7.2 GlaxoSmithKline
        7.2.1 GlaxoSmithKline Company Details
        7.2.2 GlaxoSmithKline Business Overview
        7.2.3 GlaxoSmithKline Generic Oncology Drugs Introduction
        7.2.4 GlaxoSmithKline Revenue in Generic Oncology Drugs Business (2017-2022)
        7.2.5 GlaxoSmithKline Recent Development
    7.3 Novartis
        7.3.1 Novartis Company Details
        7.3.2 Novartis Business Overview
        7.3.3 Novartis Generic Oncology Drugs Introduction
        7.3.4 Novartis Revenue in Generic Oncology Drugs Business (2017-2022)
        7.3.5 Novartis Recent Development
    7.4 Merck
        7.4.1 Merck Company Details
        7.4.2 Merck Business Overview
        7.4.3 Merck Generic Oncology Drugs Introduction
        7.4.4 Merck Revenue in Generic Oncology Drugs Business (2017-2022)
        7.4.5 Merck Recent Development
    7.5 Celgene
        7.5.1 Celgene Company Details
        7.5.2 Celgene Business Overview
        7.5.3 Celgene Generic Oncology Drugs Introduction
        7.5.4 Celgene Revenue in Generic Oncology Drugs Business (2017-2022)
        7.5.5 Celgene Recent Development
    7.6 Teva Pharmaceutical
        7.6.1 Teva Pharmaceutical Company Details
        7.6.2 Teva Pharmaceutical Business Overview
        7.6.3 Teva Pharmaceutical Generic Oncology Drugs Introduction
        7.6.4 Teva Pharmaceutical Revenue in Generic Oncology Drugs Business (2017-2022)
        7.6.5 Teva Pharmaceutical Recent Development
    7.7 Mylan
        7.7.1 Mylan Company Details
        7.7.2 Mylan Business Overview
        7.7.3 Mylan Generic Oncology Drugs Introduction
        7.7.4 Mylan Revenue in Generic Oncology Drugs Business (2017-2022)
        7.7.5 Mylan Recent Development
    7.8 Aurobindo Pharma
        7.8.1 Aurobindo Pharma Company Details
        7.8.2 Aurobindo Pharma Business Overview
        7.8.3 Aurobindo Pharma Generic Oncology Drugs Introduction
        7.8.4 Aurobindo Pharma Revenue in Generic Oncology Drugs Business (2017-2022)
        7.8.5 Aurobindo Pharma Recent Development
    7.9 Hikma Pharmaceuticals
        7.9.1 Hikma Pharmaceuticals Company Details
        7.9.2 Hikma Pharmaceuticals Business Overview
        7.9.3 Hikma Pharmaceuticals Generic Oncology Drugs Introduction
        7.9.4 Hikma Pharmaceuticals Revenue in Generic Oncology Drugs Business (2017-2022)
        7.9.5 Hikma Pharmaceuticals Recent Development
    7.10 Natco Pharma
        7.10.1 Natco Pharma Company Details
        7.10.2 Natco Pharma Business Overview
        7.10.3 Natco Pharma Generic Oncology Drugs Introduction
        7.10.4 Natco Pharma Revenue in Generic Oncology Drugs Business (2017-2022)
        7.10.5 Natco Pharma Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Generic Oncology Drugs Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Generic Oncology Drugs Market Trends
    Table 3. Generic Oncology Drugs Market Drivers
    Table 4. Generic Oncology Drugs Market Challenges
    Table 5. Generic Oncology Drugs Market Restraints
    Table 6. Global Generic Oncology Drugs Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Generic Oncology Drugs Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Generic Oncology Drugs Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Generic Oncology Drugs Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Generic Oncology Drugs Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Generic Oncology Drugs Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Generic Oncology Drugs Revenue Share by Player, 2017-2022
    Table 13. Global Generic Oncology Drugs Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Generic Oncology Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Oncology Drugs as of 2021)
    Table 15. Top Players of Generic Oncology Drugs in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Generic Oncology Drugs Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Generic Oncology Drugs Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Generic Oncology Drugs Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Generic Oncology Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Generic Oncology Drugs Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Generic Oncology Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Generic Oncology Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Generic Oncology Drugs Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Generic Oncology Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Generic Oncology Drugs Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Generic Oncology Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Generic Oncology Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Generic Oncology Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Pfizer Company Details
    Table 31. Pfizer Business Overview
    Table 32. Pfizer Generic Oncology Drugs Product
    Table 33. Pfizer Revenue in Generic Oncology Drugs Business (2017-2022) & (US$ Million)
    Table 34. Pfizer Recent Development
    Table 35. GlaxoSmithKline Company Details
    Table 36. GlaxoSmithKline Business Overview
    Table 37. GlaxoSmithKline Generic Oncology Drugs Product
    Table 38. GlaxoSmithKline Revenue in Generic Oncology Drugs Business (2017-2022) & (US$ Million)
    Table 39. GlaxoSmithKline Recent Development
    Table 40. Novartis Company Details
    Table 41. Novartis Business Overview
    Table 42. Novartis Generic Oncology Drugs Product
    Table 43. Novartis Revenue in Generic Oncology Drugs Business (2017-2022) & (US$ Million)
    Table 44. Novartis Recent Development
    Table 45. Merck Company Details
    Table 46. Merck Business Overview
    Table 47. Merck Generic Oncology Drugs Product
    Table 48. Merck Revenue in Generic Oncology Drugs Business (2017-2022) & (US$ Million)
    Table 49. Merck Recent Development
    Table 50. Celgene Company Details
    Table 51. Celgene Business Overview
    Table 52. Celgene Generic Oncology Drugs Product
    Table 53. Celgene Revenue in Generic Oncology Drugs Business (2017-2022) & (US$ Million)
    Table 54. Celgene Recent Development
    Table 55. Teva Pharmaceutical Company Details
    Table 56. Teva Pharmaceutical Business Overview
    Table 57. Teva Pharmaceutical Generic Oncology Drugs Product
    Table 58. Teva Pharmaceutical Revenue in Generic Oncology Drugs Business (2017-2022) & (US$ Million)
    Table 59. Teva Pharmaceutical Recent Development
    Table 60. Mylan Company Details
    Table 61. Mylan Business Overview
    Table 62. Mylan Generic Oncology Drugs Product
    Table 63. Mylan Revenue in Generic Oncology Drugs Business (2017-2022) & (US$ Million)
    Table 64. Mylan Recent Development
    Table 65. Aurobindo Pharma Company Details
    Table 66. Aurobindo Pharma Business Overview
    Table 67. Aurobindo Pharma Generic Oncology Drugs Product
    Table 68. Aurobindo Pharma Revenue in Generic Oncology Drugs Business (2017-2022) & (US$ Million)
    Table 69. Aurobindo Pharma Recent Development
    Table 70. Hikma Pharmaceuticals Company Details
    Table 71. Hikma Pharmaceuticals Business Overview
    Table 72. Hikma Pharmaceuticals Generic Oncology Drugs Product
    Table 73. Hikma Pharmaceuticals Revenue in Generic Oncology Drugs Business (2017-2022) & (US$ Million)
    Table 74. Hikma Pharmaceuticals Recent Development
    Table 75. Natco Pharma Company Details
    Table 76. Natco Pharma Business Overview
    Table 77. Natco Pharma Generic Oncology Drugs Product
    Table 78. Natco Pharma Revenue in Generic Oncology Drugs Business (2017-2022) & (US$ Million)
    Table 79. Natco Pharma Recent Development
    Table 80. Research Programs/Design for This Report
    Table 81. Key Data Information from Secondary Sources
    Table 82. Key Data Information from Primary Sources
List of Figures
    Figure 1. Generic Oncology Drugs Product Picture
    Figure 2. Global Generic Oncology Drugs Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Generic Oncology Drugs Market Size 2017-2028 (US$ Million)
    Figure 4. United States Generic Oncology Drugs Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Generic Oncology Drugs Market Size 2017-2028 (US$ Million)
    Figure 6. United States Generic Oncology Drugs Market Share in Global 2017-2028
    Figure 7. Generic Oncology Drugs Report Years Considered
    Figure 8. Product Picture of Large Molecule Drugs
    Figure 9. Product Picture of Small Molecule Drugs
    Figure 10. Global Generic Oncology Drugs Market Share by Type in 2022 & 2028
    Figure 11. Global Generic Oncology Drugs Market Size by Type (2017-2028) & (US$ Million)
    Figure 12. Global Generic Oncology Drugs Market Share by Type (2017-2028)
    Figure 13. United States Generic Oncology Drugs Market Share by Type in 2022 & 2028
    Figure 14. United States Generic Oncology Drugs Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. United States Generic Oncology Drugs Market Share by Type (2017-2028)
    Figure 16. Product Picture of Hospital Pharmacies
    Figure 17. Product Picture of Retail Pharmacies
    Figure 18. Product Picture of Online Pharmacies
    Figure 19. Global Generic Oncology Drugs Market Share by Application in 2022 & 2028
    Figure 20. Global Generic Oncology Drugs Market Size by Application (2017-2028) & (US$ Million)
    Figure 21. Global Generic Oncology Drugs Market Share by Application (2017-2028)
    Figure 22. United States Generic Oncology Drugs Market Share by Application in 2022 & 2028
    Figure 23. United States Generic Oncology Drugs Market Size by Application (2017-2028) & (US$ Million)
    Figure 24. United States Generic Oncology Drugs Market Share by Application (2017-2028)
    Figure 25. North America Generic Oncology Drugs Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 26. U.S. Generic Oncology Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 27. Canada Generic Oncology Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 28. Europe Generic Oncology Drugs Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 29. Germany Generic Oncology Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. France Generic Oncology Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. U.K. Generic Oncology Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Italy Generic Oncology Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Russia Generic Oncology Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Generic Oncology Drugs Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 35. China Generic Oncology Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Japan Generic Oncology Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. South Korea Generic Oncology Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. India Generic Oncology Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Australia Generic Oncology Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Taiwan Generic Oncology Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Indonesia Generic Oncology Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Thailand Generic Oncology Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Malaysia Generic Oncology Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Philippines Generic Oncology Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Latin America Generic Oncology Drugs Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 46. Mexico Generic Oncology Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Brazil Generic Oncology Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Argentina Generic Oncology Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Generic Oncology Drugs Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 50. Turkey Generic Oncology Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Saudi Arabia Generic Oncology Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. U.A.E Generic Oncology Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Pfizer Revenue Growth Rate in Generic Oncology Drugs Business (2017-2022)
    Figure 54. GlaxoSmithKline Revenue Growth Rate in Generic Oncology Drugs Business (2017-2022)
    Figure 55. Novartis Revenue Growth Rate in Generic Oncology Drugs Business (2017-2022)
    Figure 56. Merck Revenue Growth Rate in Generic Oncology Drugs Business (2017-2022)
    Figure 57. Celgene Revenue Growth Rate in Generic Oncology Drugs Business (2017-2022)
    Figure 58. Teva Pharmaceutical Revenue Growth Rate in Generic Oncology Drugs Business (2017-2022)
    Figure 59. Mylan Revenue Growth Rate in Generic Oncology Drugs Business (2017-2022)
    Figure 60. Aurobindo Pharma Revenue Growth Rate in Generic Oncology Drugs Business (2017-2022)
    Figure 61. Hikma Pharmaceuticals Revenue Growth Rate in Generic Oncology Drugs Business (2017-2022)
    Figure 62. Natco Pharma Revenue Growth Rate in Generic Oncology Drugs Business (2017-2022)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer
GlaxoSmithKline
Novartis
Merck
Celgene
Teva Pharmaceutical
Mylan
Aurobindo Pharma
Hikma Pharmaceuticals
Natco Pharma
Frequently Asked Questions
Generic Oncology Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Generic Oncology Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Generic Oncology Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Steel Mill Skimmer

Steel Mill Skimmer market is segmented by region (country), players, by Type and by Application.  ... Read More

Mini Skimmers

Mini Skimmers market is segmented by region (country), players, by Type and by Application. Playe ... Read More